Richard J. Massey

Chief Executive Officer at

Covalent Bioscience, Inc.

79 year

Health Technology

Profile

Richard J.
Massey was the founder of IGEN International, Inc. where he held the title of President & Chief Operating Officer from 1982 to 2011.
He is also the founder of Covalent Bioscience, Inc. In his former jobs, he held the position of President & Chief Executive Officer at BioVeris Corp.
from 2003 to 2005.

Richard J. Massey active positions

Companies	Position	Start
Covalent Bioscience, Inc. Covalent Bioscience, Inc. BiotechnologyHealth Technology Develops electrophilic vaccines	Chief Executive Officer	-

All active positions of Richard J. Massey

Former positions of Richard J. Massey

Companies	Position	End
IGEN International, Inc. IGEN International, Inc. Medical SpecialtiesHealth Technology Develops and markets biological testing systems that incorporate its proprietary electrochemiluminescence technology for used in drug discovery, diagnostic products development as well as food and environmental safety testing	Founder	2011-04-07
BioVeris Corp. BioVeris Corp. BiotechnologyHealth Technology Develops and manufactures diagnostic products	President	2005-07-31

See the detail of Richard J. Massey's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Richard J. Massey's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
BioVeris Corp. BioVeris Corp. BiotechnologyHealth Technology Develops and manufactures diagnostic products	Health Technology
IGEN International, Inc. IGEN International, Inc. Medical SpecialtiesHealth Technology Develops and markets biological testing systems that incorporate its proprietary electrochemiluminescence technology for used in drug discovery, diagnostic products development as well as food and environmental safety testing	Health Technology
Covalent Bioscience, Inc. Covalent Bioscience, Inc. BiotechnologyHealth Technology Develops electrophilic vaccines	Health Technology